Skip to main content

Targeting Parkinson's, Peninsula drug maker nabs $60M to continue Roche partnership

The companies will take a potential antibody treatment for Parkinson's — whose high-profile patients have included Muhammad Ali and Michael J. Fox — into a Phase IIb trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.